DZ2576A1 - Compositions parentérales d'alatrofloxacine. - Google Patents

Compositions parentérales d'alatrofloxacine.

Info

Publication number
DZ2576A1
DZ2576A1 DZ980186A DZ980186A DZ2576A1 DZ 2576 A1 DZ2576 A1 DZ 2576A1 DZ 980186 A DZ980186 A DZ 980186A DZ 980186 A DZ980186 A DZ 980186A DZ 2576 A1 DZ2576 A1 DZ 2576A1
Authority
DZ
Algeria
Prior art keywords
alatrofloxacin
parenteral compositions
parenteral
compositions
Prior art date
Application number
DZ980186A
Other languages
English (en)
Inventor
Robert Mark Guinn
John Francis Lambert
Subramanian Sam Guhan
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2576A1 publication Critical patent/DZ2576A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DZ980186A 1997-08-01 1998-07-29 Compositions parentérales d'alatrofloxacine. DZ2576A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
DZ2576A1 true DZ2576A1 (fr) 2003-02-22

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980186A DZ2576A1 (fr) 1997-08-01 1998-07-29 Compositions parentérales d'alatrofloxacine.

Country Status (40)

Country Link
US (1) US6194429B1 (fr)
EP (1) EP1000086B1 (fr)
JP (1) JP3463928B2 (fr)
KR (1) KR20010022495A (fr)
CN (1) CN1265671A (fr)
AP (1) AP1031A (fr)
AR (1) AR015417A1 (fr)
AT (1) ATE259827T1 (fr)
AU (1) AU734863B2 (fr)
BG (1) BG104105A (fr)
BR (1) BR9811580A (fr)
CA (1) CA2296466C (fr)
CO (1) CO4970688A1 (fr)
DE (1) DE69821767T2 (fr)
DK (1) DK1000086T3 (fr)
DZ (1) DZ2576A1 (fr)
EA (1) EA002120B1 (fr)
ES (1) ES2214716T3 (fr)
GT (1) GT199800112A (fr)
HN (1) HN1998000106A (fr)
HR (1) HRP980417B1 (fr)
HU (1) HUP0004793A3 (fr)
ID (1) ID24374A (fr)
IL (1) IL134156A0 (fr)
IS (1) IS5339A (fr)
MA (1) MA24626A1 (fr)
NO (1) NO20000485L (fr)
NZ (1) NZ502249A (fr)
OA (1) OA11281A (fr)
PA (1) PA8456701A1 (fr)
PE (1) PE103799A1 (fr)
PL (1) PL338477A1 (fr)
PT (1) PT1000086E (fr)
SK (1) SK1012000A3 (fr)
TN (1) TNSN98146A1 (fr)
TW (1) TW538043B (fr)
UY (1) UY25113A1 (fr)
WO (1) WO1999006430A1 (fr)
YU (1) YU2500A (fr)
ZA (1) ZA986874B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010635A1 (es) * 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
EP1121933A1 (fr) * 2000-02-02 2001-08-08 Pfizer Products Inc. Compositions prémélangées injectables d'alatrofloxacin
ES2320984T3 (es) 2001-04-06 2009-06-01 Affinium Pharmaceuticals, Inc. Inhibidores de fab i.
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
CA2519429C (fr) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Compositions pharmaceutiques comportant des inhibiteurs de fab i et autres antibiotiques
CA2467321A1 (fr) * 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
ES2515101T3 (es) 2004-06-04 2014-10-29 Debiopharm International Sa Derivados de acrilamida como agentes antibióticos
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Fabi 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
EP2054422B1 (fr) 2006-07-20 2017-06-14 Debiopharm International SA Dérivés d'acrylamide en tant qu'inhibiteurs de fab i
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
JP6702883B2 (ja) * 2014-04-25 2020-06-03 ノーレックス インコーポレイテッド 向神経活性ペプチドの安定な組成物
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
CA3087898A1 (fr) 2018-02-02 2019-08-08 Ripple Therapeutics Corporation Formulations de verre comprenant des dimeres steroidiens et utilisations associees
CA3176134A1 (fr) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Compositions heterodimeres et methodes pour le traitement de troubles oculaires

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
AU694149B2 (en) 1994-01-18 1998-07-16 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
US5763454A (en) 1995-06-06 1998-06-09 Pfizer, Inc. Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
WO1997000268A1 (fr) * 1995-06-15 1997-01-03 Pfizer Inc. Procede de preparation de derives d'acide azabicyclo naphtyridine carboxylique comprenant un dipeptide
ATE208790T1 (de) * 1995-08-29 2001-11-15 Pfizer Polymorphs von prodrug 6-n(l-ala-l-ala)- trovafloxacin
NZ312199A (en) 1995-08-29 1999-06-29 Pfizer Zwitterionic forms of trovafloxacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
MA24626A1 (fr) 1999-04-01
NZ502249A (en) 2001-11-30
UY25113A1 (es) 2000-12-29
GT199800112A (es) 2000-01-15
JP2001512133A (ja) 2001-08-21
EP1000086B1 (fr) 2004-02-18
EP1000086A1 (fr) 2000-05-17
PE103799A1 (es) 1999-10-25
TW538043B (en) 2003-06-21
ZA986874B (en) 2000-01-31
IL134156A0 (en) 2001-04-30
CA2296466C (fr) 2003-04-15
IS5339A (is) 2000-01-14
HRP980417B1 (en) 2002-10-31
AR015417A1 (es) 2001-05-02
JP3463928B2 (ja) 2003-11-05
ES2214716T3 (es) 2004-09-16
PT1000086E (pt) 2004-05-31
HN1998000106A (es) 1999-01-08
AU734863B2 (en) 2001-06-21
DE69821767D1 (de) 2004-03-25
HUP0004793A2 (hu) 2001-04-28
EA200000086A1 (ru) 2000-08-28
ATE259827T1 (de) 2004-03-15
DK1000086T3 (da) 2004-05-17
BR9811580A (pt) 2000-08-22
CO4970688A1 (es) 2000-11-07
SK1012000A3 (en) 2000-09-12
PL338477A1 (en) 2000-11-06
AP1031A (en) 2001-12-21
ID24374A (id) 2000-07-13
DE69821767T2 (de) 2005-01-13
TNSN98146A1 (fr) 2005-03-15
AP9801310A0 (en) 1998-09-30
YU2500A (sh) 2002-09-19
CN1265671A (zh) 2000-09-06
OA11281A (en) 2002-11-19
BG104105A (bg) 2000-08-31
HRP980417A2 (en) 1999-08-31
US6194429B1 (en) 2001-02-27
HUP0004793A3 (en) 2001-10-29
NO20000485L (no) 2000-03-27
PA8456701A1 (es) 2000-05-24
WO1999006430A1 (fr) 1999-02-11
AU8236898A (en) 1999-02-22
EA002120B1 (ru) 2001-12-24
NO20000485D0 (no) 2000-01-31
KR20010022495A (ko) 2001-03-15
CA2296466A1 (fr) 1999-02-11

Similar Documents

Publication Publication Date Title
DE69616804D1 (de) Wasserdispergierbare copolyester-ether zusammensetzungen
FI974241A0 (fi) BPM-15 -koostumukset
NO996108D0 (no) 9-oksinerytromycinderivater
DZ2576A1 (fr) Compositions parentérales d'alatrofloxacine.
NO980290D0 (no) 2(4-substituert)benzylamino-2-metylpropanamidderivater
DE69617029D1 (de) Organoton-zusammensetzungen
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
ITMI941407A0 (it) Composizioni cementizie mdf con migliorata tenacita'
PL340372A1 (en) Novel 3,6x-hemiketals of 9a-azalydes class
ID19801A (id) Turunan-turunan 5'-deoksi-sitidina
DK0975348T3 (da) Stabiliserede tibolon-sammensætninger
DE69603228T2 (de) Aluminoxanate-Zusammensetzungen
ATE206150T1 (de) Farbstoffstabilisierte zusammensetzungen
IT1272346B (it) "accessorio di raccordo".
MA26481A1 (fr) Derives d'arylsecocholadiene
FR2710673B1 (fr) Composition d'enduit de parement.
IT1293525B1 (it) Bis-acridincarbossiammidi aventi attivita' antitumorale
FR2724962B3 (fr) Tuile d'avant-toit sous-faitiere.
KR970702873A (ko) 17β-시아노-3-에톡시-17α-하이드록시-6-메틸안드로스타-3,5,9-트리엔의 합성 방법(SYNTHESIS OF 17β-CYANO-3-ETHOXY-17α-HYDROXY-6-METHYLANDROSTA-3,5,9-TRIENE)
UA1629S (uk) Набір фестонів "веснянка-5"
UA2139S (uk) Обкладинка телефонного довідника "жовті сторінки"
UA1914S (uk) Крекер "фірмовий"
ITCS970006V0 (it) "1 m"
SE9703724D0 (sv) Flexskiva "Flexigrund"
UA1916S (uk) Крекер "оригінальний"